Roche Molecular, one of four customer-focused areas of Roche Diagnostics Solutions, develops, manufactures and supplies a wide array of innovative molecular diagnostic products, tests, platforms and technologies used to identify and quantify DNA and RNA from different organisms.
The business was founded in the early 1990s following Roche’s investment in polymerase chain reaction (PCR) technology. The mission—enhance the utility of PCR in combatting disease.
The success of researchers, laboratories and point-of-care testing locations relies largely on their ability to efficiently deliver timely, reliable diagnostic results to clinicians and the patients they serve. Our industry-leading systems, broad assay menus, and advanced digital solutions are designed to address real-world needs across the entire healthcare continuum, including oncology, infectious disease and blood screening.
Roche’s leadership and continued advancement of the technique enables PCR to make real differences in the lives of patients, laboratories and healthcare professionals everywhere. Enhancing the management of infectious diseases through early and accurate diagnoses has always been a core organizational focus and continues to define who we are today.
